PTC Therapeutics (PTCT) PT Raised to $85 at RBC Capital

July 7, 2026 7:55 AM

RBC Capital analyst Brian Abrahams raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $85.00 (from $82.00) while maintaining a Sector Perform rating.

No results found